摘要
目的观察茶碱缓释片联合沙美特罗/氟替卡松治疗稳定期重度慢性阻塞性肺疾病(COPD)的临床疗效。方法将我院2011年7月至2012年7月收治的78例重度COPD稳定期患者随机分为对照组与观察组,分别采取沙美特罗/氟替卡和茶碱缓释片联合沙美特罗/氟替卡松治疗,比较两组临床治疗效果。结果观察组临床总有效率明显高于对照组;两组治疗后FEV1及FVC均明显高于对照组,且观察组增加更为明显(P<0.05)。结论茶碱缓释片联合沙美特罗/氟替卡松治疗稳定期重度COPD疗效显著,可明显改善患者肺功能和临床症状,值得推广和应用。
Objective To observe the the theophylline joint clinical efficacy of salmeterol / fluticasone treatment with stable moderate to severe COPD.Methods July 2011 July-2012 78 patients with severe stable COPD were randomly divided into a control group and the observation group,taking salmeterol / fluticasone card and theophylline sustained-release tablets combined Samet special Luo / fluticasone treatment were compared clinical outcomes.Results The clinical total effective rate was significantly higher;After treatment,FEV1 and FVC were significantly higher and more obvious increase in the observation group（P＆lt;0.05）.Conclusion Theophylline joint fluticasone treatment with stable moderate to severe COPD significant effect of salmeterol / fluorine can significantly improve patients’ lung function and clinical symptoms,worthy of promotion and application.
出处
《中国实用医药》
2013年第14期69-70,共2页
China Practical Medicine
关键词
茶碱缓释片
沙美特罗
氟替卡松
慢性阻塞性肺疾病(COPD)
Theophylline sustained-release tablets
Salmeterol / fluticasone
Chronic obstructive pulmonary disease（COPD）
